P-gp Inhibition-Based Strategies for Modulating Pharmacokinetics of Anticancer Drugs: An Update

E-ISSN： 1875-5453|17|8|806-826

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.17, Iss.8, 2016-08, pp. : 806-826

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Digoxin toxicity with SSRIs not augmented by P-gp inhibition

Reactions Weekly, Vol. 1, Iss. 1039, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

A Transcellular Assay to Assess the P-gp Inhibition in Early Stage of Drug Development

Drug Metabolism Letters, Vol. 6, Iss. 4, 2012-12 ,pp. : 285-291

Bentham Science Publishers

Access to resources Recommend Favorite

Using PET Studies of P-gp Function to Elucidate Mechanisms Underlying the Disposition of Drugs

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 17, 2010-12 ,pp. : 1799-1809

Bentham Science Publishers

Access to resources Recommend Favorite

Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer

By Patil Anand

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 36, Iss. 3, 2011-09 ,pp. : 115-119

Springer Publishing Company

Access to resources Recommend Favorite

Strategies for Targeting the Multidrug Resistance-1 (MDR1)/P-gp Transporter in Human Malignancies

Current Cancer Drug Targets, Vol. 5, Iss. 6, 2005-09 ,pp. : 445-455

Bentham Science Publishers

Access to resources Recommend Favorite